---
title: "Arvaya Healthcare Ltd (524723) — Share Price, Financials & Analysis"
symbol: "524723"
company: "Arvaya Healthcare Ltd"
canonical: "https://tapetide.com/stocks/524723"
isin: "INE491D01017"
bse_code: "524723"
sector: "Commercial Services"
industry: "Trading & Distributors"
market_cap_cr: 579.4
generated_at: "2026-09-13T18:58:43.565Z"
---

# Arvaya Healthcare Ltd (524723)

Canonical page: https://tapetide.com/stocks/524723

## Company

- **BSE Code:** 524723
- **ISIN:** INE491D01017
- **Sector:** Commercial Services
- **Industry:** Trading & Distributors
- **Macro Sector:** Services
- **Stock Type:** EQUITY
- **Listed Since:** 2021-03-10
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** bijoyhans.net

## About

Incorporated in 1985, Bijoy Hans Ltd offers medical and lifestyle solutions through physical infrastructure and digital platforms.[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:54:30.268729Z.

- **Market Cap:** ₹579.4 Cr
- **Classification:** Microcap
- **P/E (reported):** 668.4
- **EPS (TTM):** ₹-0.94
- **Book Value:** ₹12.34
- **Price to Book:** 10.29
- **Dividend Yield:** 0%
- **ROE:** 3.86%
- **ROCE:** 5.68%
- **Debt to Equity:** 0.04
- **Revenue (yearly):** ₹0 Cr
- **Net Income:** ₹-1.2 Cr
- **EBITDA:** ₹-1.37 Cr
- **52-Week High:** ₹145
- **52-Week Low:** ₹27.94
- **RSI (14):** 62.25

## Key Insights

### Strengths

- Company is almost debt free.

### Weaknesses

- Stock is trading at 10.1 times its book value
- Company has low interest coverage ratio.
- Promoter holding is low: 30.6%
- Company has a low return on equity of -4.99% over last 3 years.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 175.86% | 184.62% | — |
| ebitda margin growth | 55.56% | -100% | -100% | -100% |
| net income growth | -66.67% | — | — | 500% |
| revenue growth | 189.42% | -100% | -100% | -100% |
| roce | — | -278.06% | -146.48% | -3.29% |
| roe | — | -211.56% | -4.09% | -280.37% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 0.07 | 0.07 | 0.07 | 0.09 | 0.06 | 0.13 | 0 | 0 | 0 | 0 | 0 | 0.1 |
| Expenses | 0.16 | 0.14 | 0.26 | 0.19 | 0.23 | 0.2 | 0.19 | 0.28 | 0.33 | 0.21 | 0.7 | 0.91 |
| Operating Profit | -0.09 | -0.07 | -0.19 | -0.1 | -0.17 | -0.07 | -0.19 | -0.28 | -0.33 | -0.21 | -0.7 | -0.81 |
| OPM % | -128.57 | -100 | -271.43 | -111.11 | -283.33 | -53.85 | — | — | — | — | — | -810 |
| Other Income | 0.05 | 0.05 | 0.08 | 0.06 | 0.04 | 0.61 | 0.05 | 0.03 | 0.02 | 0.05 | 0.07 | 0.06 |
| Interest | 0 | 0 | 0.01 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 | 0 | 0.14 |
| Depreciation | 0.02 | 0.02 | 0 | 0.01 | 0.01 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | -0.06 | -0.04 | -0.12 | -0.05 | -0.14 | 0.53 | -0.15 | -0.25 | -0.31 | -0.16 | -0.63 | -0.89 |
| Tax % | 0 | 0 | 0 | 0 | 0 | 0 | 40 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -0.05 | -0.04 | -0.13 | -0.05 | -0.14 | 0.53 | -0.21 | -0.25 | -0.31 | -0.16 | -0.63 | -0.89 |
| EPS in Rs | -0.17 | -0.13 | -0.43 | -0.17 | -0.47 | 1.77 | -0.7 | -0.33 | -0.41 | -0.21 | -0.13 | -0.19 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 0.44 | 0.4 | 0.49 | 0.4 | 0.33 | 0.3 | 0.28 | 0.28 | 0 | 0.1 |
| Expenses | 0.72 | 0.65 | 0.74 | 0.66 | 0.63 | 0.82 | 0.64 | 0.79 | 1.37 | 2.15 |
| Operating Profit | -0.28 | -0.25 | -0.25 | -0.26 | -0.3 | -0.52 | -0.36 | -0.51 | -1.37 | -2.05 |
| OPM % | -63.64 | -62.5 | -51.02 | -65 | -90.91 | -173.33 | -128.57 | -182.14 | — | -2050 |
| Other Income | 0.25 | 0.23 | 0.24 | 0.21 | 0.15 | 0.14 | 0.3 | 0.74 | 0.17 | 0.2 |
| Interest | 0.01 | 0 | 0 | 0 | 0 | 0.01 | 0.01 | 0.01 | 0 | 0.14 |
| Depreciation | 0.08 | 0.06 | 0.05 | 0.04 | 0.03 | 0.06 | 0.05 | 0.02 | 0 | 0 |
| Profit before tax | -0.12 | -0.08 | -0.06 | -0.09 | -0.18 | -0.45 | -0.12 | 0.2 | -1.2 | -1.99 |
| Tax % | -8.33 | 0 | 0 | 0 | 0 | 0 | 0 | 30 | 0 | — |
| Net Profit | -0.11 | -0.08 | -0.05 | -0.09 | -0.19 | -0.44 | -0.12 | 0.14 | -1.2 | -1.99 |
| EPS in Rs | -0.37 | -0.27 | -0.17 | -0.3 | -0.63 | -1.47 | -0.4 | 0.47 | -0.25 | -0.94 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 48.02 |
| Reserves | 1.48 | 1.36 | 1.28 | 1.23 | 1.14 | 0.95 | 0.51 | 0.39 | 0.53 | 9.97 |
| Borrowings | 0.09 | 0.06 | 0.02 | 0 | 0 | 0 | 0.08 | 0.06 | 0 | 2.52 |
| Other Liabilities | 0.03 | 0.02 | 0.03 | 0.04 | 0.03 | 0.04 | 0.04 | 0.04 | 0.06 | 7.86 |
| Total Liabilities | 4.6 | 4.44 | 4.33 | 4.27 | 4.17 | 3.99 | 3.63 | 3.49 | 3.59 | 68.37 |
| Fixed Assets | 0.91 | 0.88 | 0.82 | 0.78 | 0.74 | 0.71 | 0.76 | 0.4 | 0 | 0 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0.09 | 0.12 | 0.05 | 0.05 | 0.05 | 0.14 | 0.2 | 0.38 | 0.13 | 60.78 |
| Other Assets | 3.6 | 3.44 | 3.46 | 3.44 | 3.38 | 3.14 | 2.67 | 2.71 | 3.46 | 7.59 |
| Total Assets | 4.6 | 4.44 | 4.33 | 4.27 | 4.17 | 3.99 | 3.63 | 3.49 | 3.59 | 68.37 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | -0.4 | -0.1 | 0.02 | -0.07 | -0.01 | -0.37 | -0.26 | -0.29 | 0.22 | -7.89 |
| Cash from Investing Activity | -0.12 | -0.04 | 0 | -0.01 | 0 | 0 | -0.11 | 0.32 | 0.92 | -2.33 |
| Cash from Financing Activity | 0.09 | 0 | 0 | -0.02 | 0 | 0 | 0.08 | -0.02 | -0.06 | 7.53 |
| Net Cash Flow | -0.43 | -0.14 | 0.03 | -0.1 | -0.02 | -0.37 | -0.29 | 0.01 | 1.08 | -2.69 |
| Free Cash Flow | -0.52 | -0.16 | 0.02 | -0.08 | -0.01 | -0.37 | -0.37 | 0.03 | 1.14 | -7.89 |
| CFO/OP | 143 | 36 | -8 | 28 | 4 | 123 | 50 | 81 | -49 | 576 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 30.19 | 82.95 | 91.25 | 126.63 | 118.62 | 88.48 | 109.5 | 104.29 | 0 | — |
| Inventory Days | 51.68 | 105.97 | 102.2 | 57.03 | 121.67 | 111.09 | 69.52 | 86.9 | 0 | — |
| Days Payable | 9.69 | 23.55 | 29.2 | 45.62 | 36.5 | 63.48 | 69.52 | 0 | — | — |
| Cash Conversion Cycle | 72.18 | 165.37 | 164.25 | 138.04 | 203.79 | 136.09 | 109.5 | 191.19 | 0 | — |
| Working Capital Days | 255.23 | 796.36 | 894.25 | 513.98 | 438 | 940.15 | 206.83 | 234.64 | 273.75 | — |
| ROCE % | -2.59 | -2.89 | -1.83 | -1.41 | -2.15 | -4.45 | -11.67 | -7.1 | -10.6 | -3.75 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 7.74% | 7.74% | 7.74% | 7.74% | 7.74% | 7.74% | 7.74% | 63.1% | 62.73% | 62.73% | 30.62% | 30.62% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 90.29% | 90.29% | 90.29% | 90.29% | 90.29% | 90.29% | 90.29% | 36.12% | 36.41% | 36.4% | 60.08% | 60.01% |
| Others | 1.97% | 1.97% | 1.97% | 1.97% | 1.97% | 1.97% | 1.97% | 0.79% | 0.86% | 0.87% | 9.3% | 9.37% |
| No. of Shareholders | 3188 | 3189 | 3195 | 3194 | 3195 | 3195 | 3195 | 3197 | 3196 | 3193 | 3387 | 3393 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 10 / 7 / 2

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 122.39 | Sell |
| EMA (10) | 121.91 | Buy |
| SMA (20) | 117.81 | Buy |
| EMA (20) | 118.27 | Buy |
| SMA (50) | 100.19 | Buy |
| EMA (50) | 100.7 | Buy |
| SMA (100) | 68.37 | Buy |
| EMA (100) | 73.44 | Buy |
| SMA (200) | — | Neutral |
| EMA (200) | — | Neutral |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 58.28 | Neutral |
| MACD (12,26,9) | 6.19 | Sell |
| Stochastic (14,3,3) | 59.51 | Neutral |
| ADX (14) | 36.95 | Buy |
| Williams %R (14) | -50.14 | Neutral |
| ATR (14) | 4.99 | High Volatility |
| ROC (12) | 2.52 | Buy |
| Stoch RSI (14) | 0 | Buy |
| UO (7,14,28) | 47.6 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-08-29 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=60e57070-be59-4d30-b813-44f6f9df8b7b.pdf) |
| 2026-08-28 | [Notice 41St Annual General Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f14841d6-ca76-414d-b932-0492d2fdc575.pdf) |
| 2026-08-28 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=56ac5707-7a93-4a21-8b6c-d314169cf101.pdf) |
| 2026-08-28 | [Announcement Regarding Web Links For Accessing The Notice Of The Forty First Annual General Meeting And Annual Report Of The Company.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=660417a7-9432-4f48-bb18-5a8a7502f433.pdf) |
| 2026-08-27 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=39bdab1f-4486-4f54-8bbb-a5712d80cca8.pdf) |
| 2026-08-26 | [Board Meeting Outcome for Acquisition Of Copyright And Intellectual Property Portfolio Of DEFIB INSTITUTE OF HEALTH SOLUTIONS LLP](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=48d4028e-b291-4306-a915-88d9b17f9ae4.pdf) |
| 2026-08-21 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4fcab804-9aaf-49d0-b6c0-782a353bc641.pdf) |
| 2026-08-21 | [Board Meeting Intimation for Board Meeting To Be Held On 26Th August 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=67342149-0ef8-4033-9516-0d3c2586836e.pdf) |
| 2026-08-16 | [Shareholder Meeting / Postal Ballot-Scrutinizer"s Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=828ae259-b1cf-432d-a143-7b2fc6bb980c.pdf) |
| 2026-08-13 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8abdd440-a7c5-43fc-9702-712d6221f8ec.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-12 | [Unaudited Financial Results For The First Quarter Ended 30 June 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aa4d68b9-65cc-4bb4-925e-cf297237c3eb.pdf) |
| 2026-06-03 | [Corrigendum For Financial Audited Results For 31St March 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8429b51b-a8ad-470d-a21d-57ee819feaf2.pdf) |
| 2026-06-03 | [Corrigendum For Audited Financial Results Of 31St March 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aab0f0e3-b89d-4d08-ab4e-841e65358bb4.pdf) |
| 2026-05-28 | [Audited Financial Results For The Year Ended 31 March 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=60e5b25f-ff13-42ba-aa73-f28bf8242145.pdf) |
| 2026-02-13 | [Unaudited Financial Results For The Quarter Ended 31 December 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3b54cd3d-2380-4908-b662-8251ae3826f9.pdf) |
| 2025-11-06 | [Unaudited Financial Results For The Quarter And Half Year Ended 30Th September 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1b77bc01-cc02-41d8-911d-6dedc82c30ad.pdf) |
| 2025-07-28 | [Financial Result For The Quarter Ended 30Th June 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7119e509-9db7-46f3-89d2-fbfe442aab10.pdf) |
| 2025-02-04 | [Unaudited Financial Results For The Quarter Ended 31St December 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=986c3ab6-4ee2-4b33-9631-bfae52806ae5.pdf) |
| 2024-11-09 | [Unaudited Financial Results For Quarter And Half Year Ended 30Th September, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=090b13b8-b2b6-42dc-8a1f-ed43c8dc25b4.pdf) |
| 2024-08-13 | [Financial Results For Quarter Ended 30Th June, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=70eb3b23-679d-4db0-9972-7e5c1ccd8416.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9h - Board meeting on March 4, 2026 to consider promoter reclassification request by Patwari family. | [Board Meeting Intimation for Re-Classification Of A Promoter/Non Promoter Group Into Public Category 9h - Board meeting on March 4, 2026 to consider promoter reclassification request by Patwari family.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/a2af5cbd-cef6-4587-9af1-996a35af3f45.pdf) |
| 9h - Board meeting on 17-Mar-2026 to propose name change, higher borrowing limits, management changes, remuneration, authorised capital increase, postal ballot, scrutinizer appointment, loans/guarantees approval. | [Board Meeting Intimation for Board Of The Company To Be Held On 17 March 2026 9h - Board meeting on 17-Mar-2026 to propose name change, higher borrowing limits, management changes, remuneration, authorised capital increase, postal ballot, scrutinizer appointment, loans/guarantees approval.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/829a5f32-4d3c-4f9c-a3a9-61ad0146112e.pdf) |
| 9h - Board approved reclassification of four promoters to public; subject to stock exchange approval, March 4, 2026. | [Intimation Under Regulation 30 Of SEBI LODR 9h - Board approved reclassification of four promoters to public; subject to stock exchange approval, March 4, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/c8014c27-4b7d-4101-9aa5-2ac0117c6af2.pdf) |
| 9h - Allotment of 4,05,21,836 shares at Rs12.50 (aggregate ₹50.65 crore); three firms acquired, now wholly owned; promoters reclassified. | [Announcement under Regulation 30 (LODR)-Allotment 9h - Allotment of 4,05,21,836 shares at Rs12.50 (aggregate ₹50.65 crore); three firms acquired, now wholly owned; promoters reclassified.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/ae6bc90c-5a7e-4cd7-b01d-59aa5273a806.pdf) |
| 9h - Allotment of 4,05,21,836 shares at Rs.12.50; HSHPL, AHWPL, TPSPL become wholly owned; promoters reclassified. | [Board Meeting Outcome for Outcome Of The Board Meeting Held On 4 March 2026 9h - Allotment of 4,05,21,836 shares at Rs.12.50; HSHPL, AHWPL, TPSPL become wholly owned; promoters reclassified.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/8e72b63c-6bc9-484f-8a5d-e578ac000071.pdf) |
| 9 Mar - Applied to BSE on 8 Mar 2026 to reclassify four promoters to public; each holds 0.00 shares. | [Announcement Under SEBI LODR, 2015 Regulation 31 (8) (C). 9 Mar - Applied to BSE on 8 Mar 2026 to reclassify four promoters to public; each holds 0.00 shares.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c0f06515-d22d-44f1-91d6-033eacecab73.pdf) |
| 9 Feb - Preferential allotment revised to 9,999,879 shares at ₹12.50 due to 121-share computational correction. | [Announcement Under Regulation 30_Update 9 Feb - Preferential allotment revised to 9,999,879 shares at ₹12.50 due to 121-share computational correction.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ca7c0e45-4a8c-42fc-9e3e-6160af514380.pdf) |
| 8 Apr - Promoters filed yearly disclosure under SEBI Regulation 31(4) for FY ended 31 March 2026. | [Disclosure Under Regulation 31(4) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulation, 2011 8 Apr - Promoters filed yearly disclosure under SEBI Regulation 31(4) for FY ended 31 March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/497c6f60-805b-4350-b451-f2de4f2601bb.pdf) |
| 3h - Withdrew 'Arvaya Healthtech' name; approved proposed change to 'Arvaya Healthcare' or 'Arvaya Healthcare and Wellness' on Mar 11, 2026. | [Board Meeting Outcome for Outcome Of The Board Meeting Held On 11 March 2026 3h - Withdrew 'Arvaya Healthtech' name; approved proposed change to 'Arvaya Healthcare' or 'Arvaya Healthcare and Wellness' on Mar 11, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/25ce6578-7e15-4c17-8368-cd7f562b762e.pdf) |
| 3 Apr - BSE approved listing of 4.05-crore preferential equity shares at Rs 12.50 on April 2, 2026. | [Intimation Of Listing Approval Received From BSE Limited For 4,05,21,836 Equity Shares Of Rs. 10/- Each Issued At A Premium Of Rs. 2.50/-. 3 Apr - BSE approved listing of 4.05-crore preferential equity shares at Rs 12.50 on April 2, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/bff9fa3d-82a5-439d-a38c-8ae49348e132.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Oct 2020 | [Concall - Oct 2020](https://archives.nseindia.com/corporate/DPABHUSHAN_19102020170404_INVESTORPRESENTATION.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/48245c7c-8df9-4458-ae7f-56d8ce598291.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ebd52425-d201-4238-a91b-2c05b29446e3.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://nsearchives.nseindia.com/corporate/DPABHUSHAN_17112023152457_investorpresentation.pdf) |
| May 2025 | [Concall - May 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/012732a2-5a76-48f4-a8c7-892d63fa54ab.pdf) |
| May 2024 | [Concall - May 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2298aeef-c32f-4f4b-8737-f1755494df81.pdf) |
| May 2024 | [Concall - May 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/5515a992-1337-4777-889c-9eafaae2eaaa.pdf) |
| May 2022 | [Concall - May 2022](https://archives.nseindia.com/corporate/DPABHUSHAN_26052022154437_TRANSCRIPT.pdf) |
| Jul 2024 | [Concall - Jul 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9013a7af-9dd0-47f8-93e1-ad70653d302e.pdf) |
| Feb 2025 | [Concall - Feb 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/bff0de4c-aad2-48e7-bf7b-5699da38c703.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Financial Year 2023 from nse](https://archives.nseindia.com/annual_reports/AR_23880_DPABHUSHAN_2022_2023_08092023202857_09082023210004.zip) |
| from nse | [Financial Year 2022 from nse](https://archives.nseindia.com/annual_reports/AR_21748_DPABHUSHAN_2021_2022_08092022202122_09082022210015.zip) |
| from nse | [Financial Year 2021 from nse](https://archives.nseindia.com/annual_reports/AR_19595_DPABHUSHAN_2020_2021_07092021161814_09072021170013.zip) |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ddd3a0ac-de61-45ce-9738-5bc98c2c6d01.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/34065117-d9a8-4e84-a714-5c30c336f166.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7fce6bd9-e8fa-4da3-bff5-daeecbf9565d.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/546c8233-3279-45ed-8e56-62257f3f0a38.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e7933569-8e73-4cdc-9810-92987361ddab.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/524723/74664524723.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/524723/69851524723.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:58:43.565Z.